Certara
IPOAccelerating medicines to patients with biosimulation, technology and services
Public · Radnor, United States · Founded 2008 · $850.0M raised
- Headquarters
- Radnor, Pennsylvania
- Employees
- 1001–5000
- Founded
- 2008
- Business Model
- B2B
- Website
- certara.com
- Total Funding
- $850.0M
- Last Round
- $850.0M Private EquityJan 2017
- Rounds
- 1
- Type
- Public
About
Global biosimulation software and services company accelerating drug development for 2,000+ biopharma clients across 62 countries.
Summary
Certara is a Life Sciences company based in Radnor, United States, founded in 2008. It has raised $850.0M in total across 1 round, most recently a $850.0M Private Equity round in Jan 2017. Investors include EQT Ventures and Arsenal Capital Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Global contract research organization providing comprehensive drug development and laboratory ser...